548 Results

People

  1. Rossi
    Rossi
  2. Dee
    Dee
  3. Marghoob
    Marghoob
  4. Dogan
    Dogan
  5. Dusza
    Dusza
  6. Giralt
    Giralt
  7. Perales
    Perales
  8. Marchetti
    Marchetti
  9. Nehal
    Nehal
  10. Salles
    Salles

Groups

  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)
  7. Population Sciences Research Program (116)
  8. GSK Faculty (96)
  9. Dermatology Service (87)
  10. Dermatology (86)
  1. "Research letter"
Formats
  1. Research Letter (548)
Groups
  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)

More Groups

People
  1. Anthony Rossi (23)
  2. Edward Christopher Dee (21)
  3. Ashfaq Marghoob (19)
  4. Ahmet Dogan (18)
  5. Michael Marchetti (18)
  6. Miguel-Angel Perales (17)

More People

Years
  1. 2025 (42)
  2. 2024 (89)
  3. 2023 (101)
  4. 2022 (82)
  5. 2021 (91)
  6. 2020 (95)

More Years

Publications
  1. Journal of the American Academy of Dermatology (46)
  2. Blood Advances (31)
  3. Haematologica (25)
  4. Leukemia (25)
  5. Bone Marrow Transplantation (18)
  6. American Journal of Hematology (17)

More Publications

Publishers
  1. Nature Publishing Group (97)
  2. Mosby Elsevier (49)
  3. American Medical Association (45)
  4. American Society of Hematology (44)
  5. Wiley Blackwell (34)
  6. Elsevier Inc. (29)

More Publishers

Results (548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Research Letter

    Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Risk factors for postoperative wound dehiscence after skin repair: A case-control study
    Research Letter

    Alam, M.; Harikumar, V.; Reynolds, K. A.; Hsu, D. Y.; Lazaroff, J. M.; Chen, B. R.; Jain-Poster, K.; Gwillim, E. C.; Ibrahim, S.; Kang, B. Y.; more...
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Utilization of National Cancer Institute-designated cancer centers by Medicare beneficiaries with cancer
    Research Letter

    Erfani, P.; Ojo, A.; John Orav, E.; Chino, F.; Lam, M. B.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia
    Research Letter

    Witkowski, M. T.; Lee, S.; Wang, E.; Lee, A. K.; Talbot, A.; Ma, C.; Tsopoulidis, N.; Brumbaugh, J.; Zhao, Y.; Roberts, K. G.; more...
    Nature Immunology (2022)

    Fulltext@MSK | Save
  • What constitutes a clear margin in Mohs surgery?
    Research Letter

    Phillips, W.; Shah, K.; Lee, E. H.; Nehal, K.
    Dermatologic Surgery (2022)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and differential outcomes after immune checkpoint blockade
    Research Letter

    Hsiehchen, D.; Sfreddo, H. J.; Zhao, K.; Han, C. Y.; Morris, L. G. T.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
    Research Letter

    Rosenbaum, C. A.; Özbek, U.; Sanchez, L.; Lagdameo, J.; Abrahams, A.; Hassoun, H.; Lahoud, O.; Niesvizky, R.; Landau, H. J.; Osman, K.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
    Research Letter

    Rapaport, F.; Seier, K.; Neelamraju, Y.; Hassane, D.; Baslan, T.; Gildea, D. T.; Haddox, S.; Lee, T.; Murdock, H. M.; Sheridan, C.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
    Research Letter

    Zhang, J.; Wang, T.; Shetty, K.; Alkan, S.; Xu, S.; Gong, Q.; Liu, X.; Li, Y.; Hu, Z.; Huang, W.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma
    Research Letter

    Soumerai, J. D.; Rosenthal, A.; Harkins, S.; Duffy, J.; Mecca, C.; Wang, Y.; Grewal, R. K.; El-Jawahri, A. R.; Liu, H.; Menard, C.; more...
    Blood (2022)

    Fulltext@MSK | Save